CRON
Price
$2.04
Change
+$0.04 (+2.00%)
Updated
Jul 3 closing price
Capitalization
1B
32 days until earnings call
TLRY
Price
$0.54
Change
+$0.05 (+10.20%)
Updated
Jul 3 closing price
Capitalization
1.87B
17 days until earnings call
Interact to see
Advertisement

CRON vs TLRY

Header iconCRON vs TLRY Comparison
Open Charts CRON vs TLRYBanner chart's image
Cronos Group
Price$2.04
Change+$0.04 (+2.00%)
Volume$1.94M
Capitalization1B
Tilray Brands
Price$0.54
Change+$0.05 (+10.20%)
Volume$43.04M
Capitalization1.87B
CRON vs TLRY Comparison Chart in %
Loading...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRON vs. TLRY commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Buy and TLRY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CRON: $2.04 vs. TLRY: $0.54)
Brand notoriety: CRON: Not notable vs. TLRY: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRON: 114% vs. TLRY: 169%
Market capitalization -- CRON: $1B vs. TLRY: $1.87B
CRON [@Pharmaceuticals: Other] is valued at $1B. TLRY’s [@Pharmaceuticals: Other] market capitalization is $1.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 0 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • CRON’s FA Score: 0 green, 5 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, TLRY is a better buy in the long-term than CRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 4 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).

  • CRON’s TA Score: 4 bullish, 6 bearish.
  • TLRY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Other) experienced а +6.81% price change this week, while TLRY (@Pharmaceuticals: Other) price change was +30.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

CRON is expected to report earnings on Aug 07, 2025.

TLRY is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.87B) has a higher market cap than CRON($1.01B). CRON YTD gains are higher at: 0.990 vs. TLRY (-59.496). CRON has higher annual earnings (EBITDA): -71.8M vs. TLRY (-1.23B). CRON has more cash in the bank: 862M vs. TLRY (260M). CRON has less debt than TLRY: CRON (2.55M) vs TLRY (529M). TLRY has higher revenues than CRON: TLRY (700M) vs CRON (87.2M).
CRONTLRYCRON / TLRY
Capitalization1.01B1.87B54%
EBITDA-71.8M-1.23B6%
Gain YTD0.990-59.496-2%
P/E RatioN/A8.52-
Revenue87.2M700M12%
Total Cash862M260M332%
Total Debt2.55M529M0%
FUNDAMENTALS RATINGS
CRON vs TLRY: Fundamental Ratings
CRON
TLRY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8496
PRICE GROWTH RATING
1..100
5363
P/E GROWTH RATING
1..100
7995
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (48) in the Biotechnology industry is in the same range as CRON (56) in the Pharmaceuticals Other industry. This means that TLRY’s stock grew similarly to CRON’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRON (100) in the Pharmaceuticals Other industry. This means that TLRY’s stock grew similarly to CRON’s over the last 12 months.

CRON's SMR Rating (84) in the Pharmaceuticals Other industry is in the same range as TLRY (96) in the Biotechnology industry. This means that CRON’s stock grew similarly to TLRY’s over the last 12 months.

CRON's Price Growth Rating (53) in the Pharmaceuticals Other industry is in the same range as TLRY (63) in the Biotechnology industry. This means that CRON’s stock grew similarly to TLRY’s over the last 12 months.

CRON's P/E Growth Rating (79) in the Pharmaceuticals Other industry is in the same range as TLRY (95) in the Biotechnology industry. This means that CRON’s stock grew similarly to TLRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONTLRY
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 27 days ago
84%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HOOSX29.800.20
+0.68%
Hartford Schroders US Small Cap Opps R4
PBEAX23.750.13
+0.55%
PGIM Jennison Value A
WASAX23.370.10
+0.43%
Macquarie Asset Strategy Fund Cl A
NLSAX19.220.08
+0.42%
Neuberger Berman Long Short A
MUNDX26.300.08
+0.31%
Mundoval

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been loosely correlated with TLRY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRON jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+2.00%
TLRY - CRON
61%
Loosely correlated
+11.03%
OGI - CRON
59%
Loosely correlated
+3.62%
CGC - CRON
58%
Loosely correlated
+7.56%
ACB - CRON
56%
Loosely correlated
+1.57%
AMRX - CRON
32%
Poorly correlated
+0.60%
More

TLRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been loosely correlated with CGC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if TLRY jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
+11.03%
CGC - TLRY
63%
Loosely correlated
+7.56%
CRON - TLRY
61%
Loosely correlated
+2.00%
OGI - TLRY
61%
Loosely correlated
+3.62%
ACB - TLRY
55%
Loosely correlated
+1.57%
ELAN - TLRY
37%
Loosely correlated
-0.54%
More